Kiniksa Pharmaceuticals, Ltd. financial statements, including revenue, expenses, profit, and loss

The total revenue of KNSA for the last quarter is 79.86 M USD, and it's 4.24% lower compared to the previous quarter. The net income of Q1 24 is -17.70 M USD.